The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice

Fitoterapia

Volumn 86, Issue 1, 2013, Pages 84-91

  Hao, Yuqin ^a   Huang, Weixing ^a   Liao, Mingmei ^b   Zhu, Yude ^a   Liu, Hong ^a   Hao, Chunguang ^a   Liu, Guodong ^a   Zhang, Guohui ^a   Feng, Hongxia ^a   Ning, Xiaohong ^a   Li, Henggui ^a   Li, Zhehai ^a  

^a Baogang Hospital   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

p53; Resveratrol; Squamous cell carcinoma; Survivin; Xenografts

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P53; RESVERATROL; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY MASS; CANCER INHIBITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SKIN CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR CELL; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHYTOTHERAPY; PLANT EXTRACTS; REPRESSOR PROTEINS; RNA, MESSENGER; SKIN NEOPLASMS; STILBENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53; VERATRUM;

ANIMALIA; MUS MUSCULUS; SAL VIEJA VIRUS; VERATRUM;

EID: 84876384853     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.02.005     Document Type: Article

References (29)

1. M.H. Aziz, S. Reagan-Shaw, J. Wu, B.J. Longley, and N. Ahmad Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease FASEB J 19 2005 1193 1195
2. M.J. Burkitt, and J. Duncan Effects of trans-resveratrol on copper dependent hydroxyl radical formation and DNA damage: evidence for hydroxyl radical scavenging and a novel, glutathione-sparing mechanism of action Arch Biochem Biophys 381 2000 253 263
3. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, and C.W. Beecher Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
4. S. Das, and D.K. Das Resveratrol: a therapeutic promise for cardiovascular diseases Recent Pat Cardiovasc Drug Discov 2 2007 133 138
5. T. Araki, Y. Sasaki, and J. Milbrandt Increased nuclear NAD biosyn thesis and SIRT1 activation prevent axonal degeneration Science 305 2004 1010 1013
6. S. Fulda, and K.M. Debatin Sensitization for tumor necrosis factor related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol Cancer Res 64 2004 337 346
7. Q. Zhang, X. Tang, Q.Y. Lu, Z.F. Zhang, J. Brown, and A.D. Le Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor 1A and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells Mol Cancer Ther 4 2005 1465 1474
8. G. Gatouillat, E. Balasse, D. Joseph-Pietras, H. Morjani, and C. Madoulet Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma J Cell Biochem 110 2010 893 902
9. D. Colin, A. Gimazane, G. Lizard, J.C. Izard, E. Solary, and N. Latruffe Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells Int J Cancer 124 2009 2780 2788
10. H.Q. Jiao, R. Wang, H.M. Sun, Y. Liu, M. Guo, and H.X. Su Resveratrol on the growth of human skin cancer cell line A431 and its underlying mechanism J Cap Med Univ 30 2009 212 217
11. P. Roy, N. Kalra, S. Prasad, J. George, and Y. Shukla Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways Pharm Res 26 2009 211 217
12. K.B. Harikumar, A.B. Kunnumakkara, G. Sethi, P. Diagaradjane, P. Anand, and M.K. Pandey Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer Int J Cancer 127 2 2010 257 268
13. L.J. Hofseth, S.P. Hussain, and C.C. Harris p53: 25 years after its discovery Trends Pharmacol Sci 25 2004 177 181
14. N. Kalra, P. Roy, S. Prasad, and Y. Shukla Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis Life Sci 82 2008 348 358
15. L. Kai, S.K. Samuel, and A.S. Levenson Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex Int J Cancer 126 7 2010 1538 1548
16. T. Sakamoto, H. Horiguchi, E. Oguma, and F. Kayama Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells J Nutr Biochem 21 2010 856 864
17. Q.B. She, A.M. Bode, W.Y. Ma, N.Y. Chen, and Z. Dong Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinasev Cancer Res 61 2001 1604 1610
18. C. Lin, D.R. Crawford, S. Lin, J. Hwang, A. Sebuyira, and R. Meng Inducible COX-2-dependent apoptosis in human ovarian cancer cells Carcinogenesis 32 2011 19 26
19. A. Shih, F.B. Davis, H.Y. Lin, and P.J. Davis Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK-and p53-dependent mechanism J Clin Endocrinol Metab 87 2002 1223 1232
20. H.Y. Lin, H.Y. Tang, F.B. Davis, and P.J. Davis Resveratrol and apoptosis Ann N Y Acad Sci 1215 2011 79 88
21. I. Porebska, E. Sobańska, M. Kosacka, and R. Jankowska Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer Cancer Genomics Proteomics 7 2010 331 335
22. H. Lu, M. Gan, G. Zhang, T. Zhou, M. Yan, and S. Wang Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis Eur J Gynaecol Oncol 31 2010 662 666
23. W. Zhao, P. Bao, H. Qi, and H. You Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells Oncol Rep 23 2010 279 286
24. K. Wolanin, and K. Piwocka Role of survivin in mitosis Postepy Biochem 53 2007 10 18
25. M. Ikeda, I. Okamoto, and K. Tamura Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G(2)-Marrest in A549 cells Cancer Lett 248 2007 292 298
26. T. Nardiello, A.A. Jungbluth, A. Mei, M. Diliberto, X. Huang, and A. Dabrowski MAGE-A inhibits apoptosis in proliferating myeloma cells through \repression of Bax and maintenance of surviving Clin Cancer Res 17 2011 4309 4319
27. M. Adamkov, E. Halasova, J. Rajcani, M. Bencat, D. Vybohova, and S. Rybarova Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas Med Sci Monit 17 2011 74 80
28. E. Halasova, M. Adamkov, T. Matakova, E. Kavcova, I. Poliacek, and A. Singliar Lung cancer incidence and survival in chromium exposed individuals with respect to expression of anti-apoptotic protein survivin and tumor suppressor P53 protein Eur J Med Res 4 2010 55 59
29. M. Kappler, H. Taubert, F. Bartel, K. Blümke, M. Panian, and H. Schmidt Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line Oncol Rep 13 2005 167 172